Bernd Gerber

22.1k total citations · 1 hit paper
140 papers, 7.3k citations indexed

About

Bernd Gerber is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Bernd Gerber has authored 140 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Cancer Research, 60 papers in Oncology and 41 papers in Pathology and Forensic Medicine. Recurrent topics in Bernd Gerber's work include Breast Cancer Treatment Studies (72 papers), Breast Lesions and Carcinomas (38 papers) and Breast Implant and Reconstruction (26 papers). Bernd Gerber is often cited by papers focused on Breast Cancer Treatment Studies (72 papers), Breast Lesions and Carcinomas (38 papers) and Breast Implant and Reconstruction (26 papers). Bernd Gerber collaborates with scholars based in Germany, United States and Austria. Bernd Gerber's co-authors include Toralf Reimer, Gϋnter von Minckwitz, Jens‐Uwe Blohmer, Sibylle Loibl, Christian Jackisch, Holger Eidtmann, J. Hilfrich, Manfred Kaufmann, Keyur Mehta and Serban Dan Costa and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Bernd Gerber

135 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

2012 1.8k citations Gϋnter von Minckwitz, Michael Untch et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Bernd Gerber

Since Specialization

Citations

This map shows the geographic impact of Bernd Gerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Gerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Gerber more than expected).

Fields of papers citing papers by Bernd Gerber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd Gerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Gerber. The network helps show where Bernd Gerber may publish in the future.

Co-authorship network of co-authors of Bernd Gerber

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd Gerber. A scholar is included among the top collaborators of Bernd Gerber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd Gerber. Bernd Gerber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prediction of recurrent gestational diabetes mellitus: a retrospective cohort study 2023 ·Archives of Gynecology and Obstetrics ·(unknown), (unknown), Bernd Gerber, Johannes Stubert	11
2	Radiological Underestimation of Tumor Size as a Relevant Risk Factor for Positive Margin Rate in Breast-Conserving Therapy of Pure Ductal Carcinoma In Situ (DCIS) 2022 ·Cancers ·(unknown), Bernd Gerber, Toralf Reimer, Johannes Stubert, Steffi Hartmann, (unknown), Angrit Stachs	4
3	Radiopaque tissue transfer and X-ray system versus standard specimen radiography for intraoperative margin assessment in breast-conserving surgery: randomized clinical trial 2022 ·BJS Open ·Angrit Stachs, (unknown), (unknown), Johannes Stubert, Toralf Reimer, Bernd Gerber, Steffi Hartmann	2
4	Preterm ETs Are Significantly Reduced Compared with Adults and Partially Reduced Compared with Term Infants 2022 ·Children ·(unknown), Antje Vogelgesang, (unknown), Anja Lange, Dirk Olbertz, Bernd Gerber, Matthias Heckmann, Johanna Ruhnau	4
5	Lost clips after targeted lymph node biopsy in breast cancer patients: Follow-up of the CLIP-study 2021 ·European Journal of Surgical Oncology ·Steffi Hartmann, Angrit Stachs, Bernd Gerber, Hellen Knauerhase, (unknown), Günther Kundt, Toralf Reimer	5
6	Survival Analysis After Neoadjuvant Chemotherapy With Trastuzumab or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the GeparQuinto (G5) Study (GBG 44) 2018 ·Journal of Clinical Oncology ·Michael Untch, Gϋnter von Minckwitz, Bernd Gerber, Christian Schem, Mahdi Rezai, Peter A. Fasching, Hans Tesch, Holm Eggemann, Claus Hanusch, Jens Huober, Christine Solbach, Christian Jackisch, Georg Kunz, Jens‐Uwe Blohmer, Maik Hauschild, Tanja Fehm, Valentina Nekljudova, Sibylle Loibl, (unknown)	40
7	Randomised, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE) 2017 ·European Journal of Cancer ·Sherko Kümmel, Stefan Paepke, Jens Huober, Christian Schem, Michael Untch, Jens‐Uwe Blohmer, W. Eiermann, Bernd Gerber, Claus Hanusch, J. Hilfrich, Christian Jackisch, Andreas Schneeweiß, Carsten Denkert, Knut Engels, Peter Klare, Peter A. Fasching, Gϋnter von Minckwitz, Nicole Burchardi, Sibylle Loibl	17
8	Standardized Ki67 Diagnostics Using Automated Scoring—Clinical Validation in the GeparTrio Breast Cancer Study 2014 ·Clinical Cancer Research ·Frederick Klauschen, Stephan Wienert, Wolfgang Schmitt, Sibylle Loibl, Bernd Gerber, Jens‐Uwe Blohmer, Jens Huober, Thomas Rüdiger, E Erbstösser, Keyur Mehta, Bianca Lederer, Manfred Dietel, Carsten Denkert, Gϋnter von Minckwitz	78
9	Local Treatment of the Axilla in Early Breast Cancer: Concepts from the National Surgical Adjuvant Breast and Bowel Project B-04 to the Planned Intergroup Sentinel Mamma Trial 2014 ·Breast Care ·Toralf Reimer, Steffi Hartmann, Angrit Stachs, Bernd Gerber	49
10	Response-Guided Neoadjuvant Chemotherapy for Breast Cancer 2013 ·Journal of Clinical Oncology ·Gϋnter von Minckwitz, Jens‐Uwe Blohmer, Serban Dan Costa, Carsten Denkert, Holger Eidtmann, W. Eiermann, Bernd Gerber, Claus Hanusch, J. Hilfrich, Jens Huober, Christian Jackisch, Manfred Kaufmann, Sherko Kümmel, Stefan Paepke, Andreas Schneeweiß, Michael Untch, Dirk M. Zahm, Keyur Mehta, Sibylle Loibl	265
11	Recurrent Breast Cancer 2010 ·Deutsches Ärzteblatt international ·Bernd Gerber, Mathias Freund, Toralf Reimer	83
12	Postoperative infections due to bladder catheters after anterior colporrhaphy: a prospective, randomized three-arm study 2010 ·International Urogynecology Journal ·(unknown), Toralf Reimer, (unknown), Sarah Green, Guenther Kundt, Bernd Gerber	17
13	Efficacy and tolerability of a local acting antiseptic agent in the treatment of vaginal dysbiosis during pregnancy 2010 ·Archives of Gynecology and Obstetrics ·Volker Briese, Gerd Neumann, (unknown), Theodor W. May, Jörg Siebert, Bernd Gerber	13
14	Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy 2009 ·Breast Cancer Research ·Silvia Darb‐Esfahani, Sibylle Loibl, Berit Müller, Marc Roller, Carsten Denkert, Martina Komor, Karsten Schlüns, Jens‐Uwe Blohmer, Jan Budczies, Bernd Gerber, Aurelia Noske, Andreas du Bois, Wilko Weichert, Christian Jackisch, Manfred Dietel, Klaus Richter, Manfred Kaufmann, Gϋnter von Minckwitz	91
15	Primary Systemic Treatment and Oncoplastic Breast Surgery – Influences and Principles 2007 ·Breast Care ·Serban‐Dan Costa, Holm Eggemann, Jens‐Uwe Blohmer, Sherko Kümmel, Bernd Gerber	3
16	How Important is the Axillary Nodal Status for Adjuvant Treatment Decisions at a Breast Cancer Multidisciplinary Tumor Board? A Survival Analysis 2007 ·Annals of Surgical Oncology ·Toralf Reimer, Rainer Fietkau, Susanne Markmann, Angrit Stachs, Bernd Gerber	7
17	Controversies in preservation of ovary function and fertility in patients with breast cancer 2007 ·Breast Cancer Research and Treatment ·Bernd Gerber, Max Dieterich, Heiner Müller, Toralf Reimer	32
18	Pregnancy-Associated Breast Cancer – Special Features in Diagnosis and Treatment 2006 ·Oncology Research and Treatment ·(unknown), Brigitte Rack, Bernd Gerber, Ingo Bauerfeind, (unknown), Darius Dian, Harald Sommer, Klaus Friese	5
19	Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone. 2005 ·PubMed ·Ioannis Mylonas, Josef Makovitzky, Udo Jeschke, Volker Briese, Klaus Friese, Bernd Gerber	56
20	Differential diagnosis of peri- and postmenopausal ovarian cysts 1999 ·Maturitas ·Toralf Reimer, Bernd Gerber, Heiner Müller, Udo Jeschke, Annette Krause, Klaus Friese	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact